Engineered human Argonaute 2 (ALTER) achieves superior C-to-U RNA editing with reduced immunogenicity

Engineered human Argonaute 2 (ALTER) delivered 1.9-fold higher C-to-U RNA editing in HEK293T cells, demonstrating reduced off-target effects and immunogenicity versus Cas13.